NETWise
NETWise, a podcast about neuroendocrine cancer, is here to help patients and caregivers navigate the world of NETs.
- Indexed episodes, last 90 days
- 1
- Latest publication
- Sep 24, 2026
- Audience
- Checking…
- Earliest in this view
- Sep 24, 2026
Latest episodes
EP 56: GLP-1s and Neuroendocrine Cancer: What Do We Know? (opens the original)
Read excerpt
What Do We Know? GLP-1 medications have transformed the treatment of diabetes and obesity, with millions of people now using drugs in this growing class. But for people living with neuroendocrine cancer, they raise an important question: Are GLP-1s safe for people with neuroendocrine cancer? The answer isn’t a simple yes or no. In this episode of NETWise, we look at what researchers and clinicians know so far about GLP-1 medications and neuroendocrine tumors—and what we still don’t know. Some ne
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.